Lacticaseibacillus rhamnosus strain:UA260 Genome sequencing. Lacticaseibacillus rhamnosus strain:UA260

Lacticaseibacillus rhamnosus UA260 has been isolated from the intestines of healthy individuals, and in vitro experiments have shown its potential to lower uric acid levels. Animal experiments have shown that it can regulate the metabolic structure of the body, especially tryptophan metabolism, improve intestinal barrier damage, and promote colonic uric acid excretion.

鼠李糖乳酪杆菌（Lacticaseibacillus rhamnosus）UA260从健康人体肠道中分离得到；体外实验显示其具备降低血尿酸水平的潜力。动物实验证实，该菌株可调节机体代谢结构，尤其以色氨酸代谢为核心，改善肠道屏障损伤，并促进结肠尿酸排泄。